MDT

100.04

+0.6%↑

A

147.78

+0.47%↑

VEEV

236.71

+1.49%↑

HQY

96.5

+3.42%↑

PHR.US

17.45

+0.98%↑

MDT

100.04

+0.6%↑

A

147.78

+0.47%↑

VEEV

236.71

+1.49%↑

HQY

96.5

+3.42%↑

PHR.US

17.45

+0.98%↑

MDT

100.04

+0.6%↑

A

147.78

+0.47%↑

VEEV

236.71

+1.49%↑

HQY

96.5

+3.42%↑

PHR.US

17.45

+0.98%↑

MDT

100.04

+0.6%↑

A

147.78

+0.47%↑

VEEV

236.71

+1.49%↑

HQY

96.5

+3.42%↑

PHR.US

17.45

+0.98%↑

MDT

100.04

+0.6%↑

A

147.78

+0.47%↑

VEEV

236.71

+1.49%↑

HQY

96.5

+3.42%↑

PHR.US

17.45

+0.98%↑

Search

Simulations Plus Inc

Abierto

SectorSanidad

18.96 -1.81

Resumen

Variación precio

24h

Actual

Mínimo

18.59

Máximo

19.51

Métricas clave

By Trading Economics

Ingresos

67M

-681K

Ventas

-2.9M

17M

P/B

Media del Sector

48.528

88.032

BPA

-0.034

Rentabilidad por dividendo

0.48

Margen de beneficios

-3.9

Empleados

212

EBITDA

327K

5.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+6.77% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.26%

Próximas Ganancias

8 ene 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

24M

368M

Apertura anterior

20.77

Cierre anterior

18.96

Noticias sobre sentimiento de mercado

By Acuity

10%

90%

2 / 373 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

6 ene 2026, 21:14 UTC

Principales Movimientos del Mercado

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

6 ene 2026, 19:23 UTC

Adquisiciones, fusiones, absorciones

OneStream to Go Private Through $6.4 Billion Hg Acquisition

6 ene 2026, 17:41 UTC

Principales Movimientos del Mercado

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

6 ene 2026, 15:46 UTC

Adquisiciones, fusiones, absorciones

Advent International Leads InPost Takeover Offer, Sky News Says

6 ene 2026, 15:37 UTC

Principales Movimientos del Mercado

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

6 ene 2026, 23:46 UTC

Charlas de Mercado

Nikkei May Decline After Hitting Record High -- Market Talk

6 ene 2026, 23:35 UTC

Charlas de Mercado

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

6 ene 2026, 23:19 UTC

Charlas de Mercado

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

6 ene 2026, 22:53 UTC

Charlas de Mercado

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

6 ene 2026, 22:03 UTC

Adquisiciones, fusiones, absorciones

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 ene 2026, 22:03 UTC

Adquisiciones, fusiones, absorciones

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

6 ene 2026, 21:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

6 ene 2026, 21:12 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

6 ene 2026, 21:12 UTC

Charlas de Mercado

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

6 ene 2026, 20:59 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

6 ene 2026, 20:40 UTC

Adquisiciones, fusiones, absorciones

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

6 ene 2026, 20:40 UTC

Adquisiciones, fusiones, absorciones

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

6 ene 2026, 20:40 UTC

Adquisiciones, fusiones, absorciones

Deal Could Be Announced Imminently, Sources Say -- WSJ

6 ene 2026, 20:40 UTC

Adquisiciones, fusiones, absorciones

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

6 ene 2026, 20:01 UTC

Charlas de Mercado

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

6 ene 2026, 19:52 UTC

Charlas de Mercado

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

6 ene 2026, 19:46 UTC

Adquisiciones, fusiones, absorciones

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

6 ene 2026, 19:08 UTC

Adquisiciones, fusiones, absorciones

OneStream to Go Private Through $6.4B Hg Acquisition

6 ene 2026, 18:28 UTC

Adquisiciones, fusiones, absorciones

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

6 ene 2026, 17:20 UTC

Charlas de Mercado
Ganancias

Financial Services Roundup: Market Talk

6 ene 2026, 17:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Health Care Roundup: Market Talk

6 ene 2026, 15:57 UTC

Charlas de Mercado

Crude Futures Ease Back From Early Gains -- Market Talk

6 ene 2026, 15:34 UTC

Charlas de Mercado
Ganancias

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

6 ene 2026, 15:27 UTC

Charlas de Mercado

German Inflation Won't Fall Much Further in 2026 -- Market Talk

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

6.77% repunte

Estimación a 12 Meses

Media 20.5 USD  6.77%

Máximo 25 USD

Mínimo 16 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

2

Comprar

3

Mantener

0

Vender

Sentimiento

By Acuity

2 / 373 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat